Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.720
+0.020 (1.18%)
At close: Sep 11, 2026, 4:00 PM EDT
1.710
-0.010 (-0.58%)
After-hours: Sep 11, 2026, 7:59 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.24 million as of September 11, 2026. Its market cap has increased by 11.69% in one year.
Market Cap
8.24M
Enterprise Value
649.98K
1-Year Change
11.69%
Ranking
Category
Stock Price
$1.72
ChartMarket Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.24M, a decrease of -99.28%. That is a compound annual growth rate of -60.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.24M | 19.11% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 9.35M |
| Skye Bioscience | 9.21M |
| Exicure | 8.97M |
| CNS Pharmaceuticals | 8.40M |
| XTL Biopharmaceuticals | 8.35M |
| Traws Pharma | 8.17M |
| Imunon | 8.14M |
| Soligenix | 7.84M |